SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: biowa who wrote (261)2/23/2000 10:41:00 AM
From: GlobalMarineRead Replies (1) | Respond to of 557
 
I agree: The company's cash basis will carry them for another year, but it's always good to keep food on the dinner table, as it were. Even a modest public offering of, say, $50 to $100 million may actually provide confidence that the company can follow through on its R & D.

Rand



To: biowa who wrote (261)2/24/2000 6:45:00 PM
From: dalroiRead Replies (1) | Respond to of 557
 
Biowa,

i for one would love a SPO on TGEN
then valuation becomes easy

"peters 20% rule"

stefaan


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News